logo
logo
HSIC stock ticker logo

Henry Schein, Inc.

NASDAQ•HSIC
CEO: Mr. Stanley M. Bergman CPA
Sector: Healthcare
Industry: Medical - Distribution
Listing Date: 1995-11-03
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Contact Information
135 Duryea Road, Melville, NY, 11747, United States
631-843-5500
www.henryschein.com
Market Cap
$8.48B
P/E (TTM)
21.8
22.6
Dividend Yield
--
52W High
$89.29
52W Low
$61.95
52W Range
44%
Rank19Top 5.6%
6.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6.2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$3.44B+0.00%
4-Quarter Trend

EPS

$0.86+0.00%
4-Quarter Trend

FCF

$338.00M+0.00%
4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Net Sales Increased 4.0% Net sales reached $13.18B USD in 2025, reflecting 2.6% internal growth and 0.9% acquisition growth.
Operating Income Grew Modestly Operating income was $653M USD in 2025, up $32M USD from $621M USD in 2024, despite restructuring costs.
Technology Segment Leads Growth Global Technology net sales increased 7.1% to $675M USD, driven by cloud platform adoption and RCM solutions.

Risk Factors

Supplier Concentration Remains Key Top 10 suppliers accounted for 24% of aggregate 2025 purchases, posing supply chain interruption risk.
Restructuring Charges Incurred Recorded $105M USD in 2025 restructuring charges related to the 2024 Plan integrating acquisitions and rightsizing.
Cyber Incident Residual Effects October 2023 cyber incident caused operational disruption; incurred $0 in direct expenses in 2025.
Regulatory and Trade Volatility Evolving political factors, including tariffs and new legislation like OBBBA, create uncertainty for global trade.

Outlook

Execute BOLD+1 Strategic Plan Focus on building complementary software, specialty, and services businesses for high growth potential.
Deepen Customer Penetration Intend to increase sales penetration across the existing base of over one million worldwide customers.
Pursue Strategic Acquisitions Acquisition strategy targets high growth, high margin businesses adding customers and expanding geographic footprint.
Planned CEO Transition New CEO, Frederick M. Lowery, appointed effective March 2, 2026, succeeding retiring CEO Bergman.

Peer Comparison

Revenue (TTM)

MOH stock ticker logoMOH
$45.08B
+7.7%
DVA stock ticker logoDVA
$13.64B
+6.5%
HSIC stock ticker logoHSIC
$13.18B
+4.0%

Gross Margin (Latest Quarter)

HALO stock ticker logoHALO
77.4%
+1.4pp
GMED stock ticker logoGMED
72.0%
+6.5pp
ALGN stock ticker logoALGN
70.8%
-5.5pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
ALGN$12.81B29.710.7%1.3%
GMED$12.35B22.912.4%2.2%
GH$11.49B-27.1164.9%83.6%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
2.8%
Moderate Growth
4Q Net Income CAGR
-2.8%
Stable Profitability
Cash Flow Stability
100%
Strong Cash Flow

Deep Research

Next earnings:May 4, 2026
|
EPS:$1.20
|
Revenue:$3.34B
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement
LTM
No Data